Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

World-Renowned Mold Illness Expert Dr. Scott McMahon Joins MoldCo as Medical Director


News provided by

Dr. Scott McMahon of Whole World Health Care

May 28, 2025, 14:24 ET

Share this article

Share toX

Share this article

Share toX

Together, They Aim to Solve One of America's Most Overlooked Health Crisis: Mold Toxicity

LOS ANGELES, May 28, 2025 /PRNewswire/ -- MoldCo, the first digital health platform dedicated to treating mold toxicity, today announced that Dr. Scott McMahon, one of the world's leading experts on Chronic Inflammatory Response Syndrome (CIRS), has joined the company as medical director.

Continue Reading
Dr. Scott McMahon, one of the world’s leading experts on mold-related illnesses and Chronic Inflammatory Response Syndrome (CIRS), is tapped as the medical director of MoldCo, the first digital health platform dedicated to treating mold toxicity,
Dr. Scott McMahon, one of the world’s leading experts on mold-related illnesses and Chronic Inflammatory Response Syndrome (CIRS), is tapped as the medical director of MoldCo, the first digital health platform dedicated to treating mold toxicity,

CIRS is a debilitating, multi-system illness triggered by exposure to mold and water-damaged buildings. Although it potentially affects millions across the United States, it remains widely misunderstood and misdiagnosed. Each year, many are misdiagnosed and suffer from a multitude of symptoms, caused by mold exposure. MoldCo and Dr. McMahon are on a mission to change that.

"I'm honored to join MoldCo to scale what I've spent years doing one patient at a time — that is, educating and treating people with mold-related illness," said Dr. McMahon. "We're giving patients answers when the medical system gives them shrugs."

Dr. McMahon has evaluated more than 2,000 patients with CIRS across 48 states nationwide and 21 countries. A board-certified pediatrician and hospitalist with more than three decades of experience, he is also an author, researcher and expert medical witness in mold litigation. He co-authored The Art and Science of CIRS Medicine with Dr. Ritchie Shoemaker, the physician who first defined the condition. He has authored or co-authored more than a dozen peer-reviewed scientific papers on mold toxicity and contributed to multiple medical textbooks.

Dr. McMahon is also recognized as a qualified CIRS medical expert for the judicial system in ten states in the United States as well as the Bahamas and Quebec, Canada. He has been involved in more than 100 disability, workers compensation and personal injury cases, testifying in ten states as well as Canada, England and the Bahamas.

Widely regarded as a leading authority in the field, Dr. McMahon is at the forefront of advancing clinical science and education to improve outcomes for those suffering from mold exposure. MoldCo was founded by venture investor Ariana Thacker after her own debilitating experience with mold toxicity. "Millions of people live in mold-contaminated environments, unaware of the biological damage occurring inside them," said Thacker. "We built MoldCo to change that reality. Dr. McMahon's leadership marks a pivotal step forward in delivering world-class care to the people who need it most."

MoldCo provides online access to lab testing, expert-led care, and protocols grounded in research. It is often 10x to 100x more affordable than traditional functional medicine clinics, with zero travel and end-to-end remote care.

MoldCo is currently accepting new patients in select states at www.moldco.com and planning a nationwide rollout by the end of 2025.

ICYMI: A New Way to Understand Mold Toxicity: The MEDICINE AND MIRACLES Podcast, Hosted by Dr. Scott McMahon
Dr. McMahon also hosts the podcast MEDICINE AND MIRACLES, exploring the science and spirituality behind healing from mold toxicity. The latest episodes -- Episode 27 (Part 1) and Episode 28 (Part 2) – feature MoldCo CEO Ariana Thacker, who shares her personal path from patient to founder.

Listen now on digital platforms everywhere, including:

  • Spotify: Link
  • Audible: Link
  • iHeartRadio: Link
  • Amazon: Link
  • And now on YouTube: Link

About Dr. Scott McMahon
Dr. McMahon received his medical degree from Creighton University and completed his pediatric residency at Duke University Medical Center. He has published over a dozen peer-reviewed papers on mold illness and is a recognized expert witness in mold-related court cases across the United States, Canada, Europe and the Bahamas.
He resides in Roswell, New Mexico, with his wife Mary and their eight children.

Learn more at medicineandmiracles.co.

About MoldCo
MoldCo is the first clinician-led, digital health platform for told Toxicity. By combining expert care with cutting-edge lab testing, MoldCo makes recovery accessible for the millions suffering from the health consequences of toxic mold exposure, without the cost, confusion, or complexity of traditional clinics.

Visit www.moldco.com to learn more.

SOURCE Dr. Scott McMahon of Whole World Health Care

21%

more press release views with 
Request a Demo

Modal title

Also from this source

HUNDREDS OF HEALTH PROFESSIONALS, ATTORNEYS, ENVIRONMENTALISTS AND PATIENTS SET TO CONVENE AT THE ANNUAL CIRSx CONFERENCE 2025 TO ADDRESS MOLD ILLNESS, WHICH AFFECTS MILLIONS OF AMERICANS

HUNDREDS OF HEALTH PROFESSIONALS, ATTORNEYS, ENVIRONMENTALISTS AND PATIENTS SET TO CONVENE AT THE ANNUAL CIRSx CONFERENCE 2025 TO ADDRESS MOLD ILLNESS, WHICH AFFECTS MILLIONS OF AMERICANS

The organizers of the Surviving Mold-CIRSx Conference 2025 is happy to announce Dr. Dale Bredesen as its keynote speaker, set to be held on June 6-8, ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Personnel Announcements

Personnel Announcements

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.